FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry
This article was originally published in The Gray Sheet
Executive Summary
A consortium of academics, manufacturers and government agencies plans to launch a national atrial fibrillation ablation registry, based on input from a variety of stakeholders at a meeting April 27 and 28 at FDA's White Oak, Md., headquarters